Michael A. Ringenberg

A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models

Giulietta Maruggi, Corey P. Mallett, Jason W. Westerbeck et al. · Molecular Therapy · 2022 · 86 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses

Jong W. Yu, Sandy Hoffman, Allison M. Beal et al. · PLoS ONE · 2015 · 85 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Nonclinical safety assessment of repeated administration and biodistribution of a novel rabies self-amplifying mRNA vaccine in rats

Alan H. Stokes, Johanne Pion, Ornella Binazon et al. · Regulatory Toxicology and Pharmacology · 2020 · 71 citations

Veterinary Medicine, Immunology, Pharmaceutical Biotechnology +14

Pharmacological Inhibition of C-C Chemokine Receptor 2 Decreases Macrophage Infiltration in the Aortic Root of the Human C-C Chemokine Receptor 2/Apolipoprotein E ^−/− Mouse: Magnetic Resonance Imaging Assessment

Alan R. Olzinski, Gregory Turner, Roberta E. Bernard et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 42 citations · Full text

Medicine, Cardiology, Pharmacology +17

The first committed step in the biosynthesis of sialic acid by <i>Escherichia coli</i> K1 does not involve a phosphorylated <i>N</i>‐acetylmannosamine intermediate

Michael A. Ringenberg, Susan M. Steenbergen, Eric R. Vimr · Molecular Microbiology · 2003 · 41 citations · Full text

Life Sciences, Microbiology, Molecular Biology +12